Professor, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong.
|Prof. Tao obtained his PhD degree from the University of Hong Kong and completed his postdoc training in Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins. He was appointed as Assistant Professor (1999) in Johns Hopkins School of Medicine, Associate Professor (2004) and full Professor (2008) in the Chinese University of Hong Kong. Prof. Tao?s research interest is cancer epigenomics: tumor methylomes, identification of novel tumor suppressor genes silenced by promoter CpG methylation and their functional/mechanistic characterization in tumorigenesis. He has published 144 papers in international journals including PNAS, JCO, Blood, HMG, Gut, Hepatol, Cancer Res and Oncogene, and 3 book chapters on epigenetics. He serves as an Academic Editor for PLoS ONE and Chinese J Cancer, a reviewer for multiple scientific journals, and a reviewer for several grant agents. He has been a vice-President of the international Epigenetics Society since 2008.|
|? Cancer epigenomics: identification of novel tumor suppressor genes and their functional/mechanistic characterization in tumorigenesis ? Development of epigenetic biomarkers and epigenetic therapeutics ? Epigenetic regulation of EBV genes and EBV-modulated aberrant epigenetic programming during EBV pathogenesis|
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : December 15, 2017